2-(1-Methylazetidin-3-yl)ethanol, 95.0%, 250mg

Ethyl 4,6-dimethoxypyrimidine-2-carboxylate, 95.0%, 1g

3-Bromo-5-chloro-1H-pyrazolo[3,4-b]pyridine, 95.0%, 1g

Phenol, 4-[2-[[2-benzo[b]thien-3-yl-9-(1-methylethyl)-9H-purin-6-yl]amino]ethyl]-, 97%, 10mg

1-Benzoylazetidin-3-ol, 98%, 10g

4-BROMO-2-(TRIFLUOROMETHYL)BENZOYL CHLORIDE, 97.0%, 1g

PFI-1, 95%, 100mg

[2-(diphenylmethoxy)ethyl]dimethylamine hydrochloride, 98.0%, 100g

Dimethyl (2S,4R)-2-((tert-butoxycarbonyl)amino)-4-(cyanomethyl)pentanedioate, 97%, 5g

Tétraméthylurée, min 99%, pour synthèse, 500 ml, emballage verre

5-Bromo-2-phenoxypyrimidine, 97.0%, 25g

(S)-4-Amino-5-phenylpentanoic acid, 98+%, 1g

5-Methylresorcinol anhydrous, 98.0%, 5g